These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7030443)

  • 21. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
    Elizur A; Segal S; Yeret A; Ben-David M
    Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
    [No Abstract]   [Full Text] [Related]  

  • 22. Importance of akinesia: plasma chlorpromazine and prolactin levels.
    Van Putten T; May PR; Wilkins JN
    Am J Psychiatry; 1980 Nov; 137(11):1446-8. PubMed ID: 7435684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)].
    Ringwald E; Lustig A; Moscovici M; Spiegel R; Vamos E
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):318-24. PubMed ID: 6111093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation.
    Chouinard G; Annable L; Steinberg S
    J Clin Psychopharmacol; 1986 Feb; 6(1):21-6. PubMed ID: 3512622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of D-or DL-propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia.
    Gruzelier JH; Hirsch SR; Weller M; Murphy C
    Acta Psychiatr Scand; 1979 Sep; 60(3):241-8. PubMed ID: 495166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerance to the prolactin-elevating effect of neuroleptics.
    Brown WA; Laughren TP
    Psychiatry Res; 1981 Dec; 5(3):317-22. PubMed ID: 6119716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
    Kolakowska T; Fraser S; Franklin M; Knox J
    Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol as a primary treatment of neuroleptic-induced akathisia.
    Irwin M; Sullivan G; Van Putten T
    Hillside J Clin Psychiatry; 1988; 10(2):244-50. PubMed ID: 2906317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose propranolol in schizophrenia.
    Sheppard GP
    Br J Psychiatry; 1979 May; 134():470-6. PubMed ID: 476356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-methyldopa-chlorpromazine combination in schizophrenic patients.
    Chouinard G; Annable L
    Neuropsychobiology; 1976; 2(2-3):118-26. PubMed ID: 796755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients.
    Hershey LA; Gift T; Atkins RW; Rivera-Calimlim L
    Psychopharmacology (Berl); 1981; 73(4):355-8. PubMed ID: 6789357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One more look at propranolol for the treatment of refractory schizophrenia.
    Berlant JL
    Schizophr Bull; 1987; 13(4):705-14. PubMed ID: 3326164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia.
    Becker RE
    Am J Psychiatry; 1983 Feb; 140(2):208-11. PubMed ID: 6336916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of propranolol and phenothiazines on electrodermal orienting and habituation in schizophrenia.
    Gruzelier J; Connolly J; Eves F; Hirsch S; Zaki S; Weller M; Yorkston N
    Psychol Med; 1981 Feb; 11(1):93-108. PubMed ID: 6111100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of propranolol treatment on serum prolactin level in schizophrenic patients.
    Elizur A; Segal Z; Yeret A; Ben-David M
    Commun Psychopharmacol; 1980; 4(3):203-6. PubMed ID: 7226751
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of chlorpromazine in serum by radioreceptor assay and HPLC.
    Krska J; Addison GM; Soni SD
    Ann Clin Biochem; 1986 May; 23 ( Pt 3)():340-5. PubMed ID: 3789642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
    Wiles DH; Kolakowska T; McNeilly AS; Mandelbrote BM; Gelder MG
    Psychol Med; 1976 Aug; 6(3):407-15. PubMed ID: 996201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of response to chlorpromazine treatment in schizophrenics.
    Sakurai Y; Nakahara T; Takahashi R
    Psychopharmacologia; 1975 Oct; 44(2):195-203. PubMed ID: 1105634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A preliminary report on clinical response and blood levels of chlorpromazine and its sulfoxide during chlorpromazine therapy in chronic schizophrenic patients.
    Clark ML; Kaul PN
    Psychopharmacol Bull; 1975 Oct; 11(4):28-30. PubMed ID: 1105638
    [No Abstract]   [Full Text] [Related]  

  • 40. Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels.
    Chetty M; Pillay VL; Moodley SV; Miller R
    Eur Neuropsychopharmacol; 1996 May; 6(2):85-91. PubMed ID: 8791032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.